CA931074A - Preparation a base d'antigenes bacteriens - Google Patents

Preparation a base d'antigenes bacteriens

Info

Publication number
CA931074A
CA931074A CA054602A CA54602A CA931074A CA 931074 A CA931074 A CA 931074A CA 054602 A CA054602 A CA 054602A CA 54602 A CA54602 A CA 54602A CA 931074 A CA931074 A CA 931074A
Authority
CA
Canada
Prior art keywords
bacteriens
antigenes
preparation
base
antigenes bacteriens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA054602A
Other languages
English (en)
Inventor
R. Illartein Paul
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Science Union et Cie
Original Assignee
Science Union et Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union et Cie filed Critical Science Union et Cie
Application granted granted Critical
Publication of CA931074A publication Critical patent/CA931074A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
CA054602A 1968-06-19 1969-06-17 Preparation a base d'antigenes bacteriens Expired CA931074A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR155603A FR7461M (de) 1968-06-19 1968-06-19

Publications (1)

Publication Number Publication Date
CA931074A true CA931074A (en) 1973-07-31

Family

ID=8651343

Family Applications (1)

Application Number Title Priority Date Filing Date
CA054602A Expired CA931074A (en) 1968-06-19 1969-06-17 Preparation a base d'antigenes bacteriens

Country Status (7)

Country Link
US (1) US3608066A (de)
BE (1) BE734775A (de)
CA (1) CA931074A (de)
DE (1) DE1931195C3 (de)
ES (1) ES368147A1 (de)
FR (1) FR7461M (de)
GB (1) GB1243601A (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686476A (en) * 1993-12-21 1997-11-11 Eli Lilly And Company Methods of inhibiting Alzheimer's Disease

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1502774A (en) * 1974-06-25 1978-03-01 Nat Res Dev Immunological preparations
DE2748132A1 (de) * 1977-10-27 1979-05-03 Behringwerke Ag Stabilisator fuer polysaccharid
US4223014A (en) * 1978-05-08 1980-09-16 The United States Of America As Represented By The Secretary Of The Interior Spray immunization of fish
CH633188A5 (fr) * 1978-05-26 1982-11-30 Om Laboratoires Sa Medicament contre des maladies infectieuses des voies respiratoires.
US4225583A (en) * 1978-12-07 1980-09-30 Iowa State University Research Foundation, Inc. Intra-respiratory vaccine for prevention of Bordetella bronchiseptica infection and method of use
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
CH664497A5 (de) * 1984-08-31 1988-03-15 Solco Basel Ag Vakzine zur behandlung der harnwegsinfektionen.
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5776434A (en) * 1988-12-06 1998-07-07 Riker Laboratories, Inc. Medicinal aerosol formulations
CA2097830C (en) * 1990-12-04 2000-02-01 Stephen G. Newman Spray-dried antigenic products and method of preparation
CA2097932A1 (en) * 1991-10-11 1993-04-12 Shojiro Yamazaki Antibody containing composition
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US6509006B1 (en) 1992-07-08 2003-01-21 Inhale Therapeutic Systems, Inc. Devices compositions and methods for the pulmonary delivery of aerosolized medicaments
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
MXPA04004726A (es) * 2001-11-19 2004-07-30 Becton Dickinson Co Composiciones farmaceuticas en forma particulada.
WO2008085549A2 (en) * 2006-07-28 2008-07-17 Board Of Regents Of The University Of Texas System Compositions and methods for stimulation of lung innate immunity
DE102007020578A1 (de) * 2007-05-02 2008-11-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Wässrige Aerosolzubereitungen enthaltend therapeutisch wirksame Mikroorganismen oder Teile von Mikroorganismen und Verfahren zur Erzeugung entsprechender Aerosole
WO2010030790A2 (en) * 2008-09-10 2010-03-18 The Texas A&M University System Methods and compositions for stimulation of mammalian innate immune resistance to pathogens
EP2411521B1 (de) 2009-03-25 2015-01-14 The Board of Regents of The University of Texas System Zusammensetzungen zur stimulierung angeborener säuger-immunresistenz gegen krankheitserreger
CN107252482A (zh) 2009-05-27 2017-10-17 西莱克塔生物科技公司 具有不同释放速率的纳米载体加工组分
US20110293701A1 (en) 2010-05-26 2011-12-01 Selecta Biosciences, Inc. Multivalent synthetic nanocarrier vaccines
CN109172819A (zh) 2011-07-29 2019-01-11 西莱克塔生物科技公司 产生体液和细胞毒性t淋巴细胞（ctl）免疫应答的合成纳米载体
WO2016044839A2 (en) 2014-09-19 2016-03-24 The Board Of Regents Of The University Of Texas System Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686476A (en) * 1993-12-21 1997-11-11 Eli Lilly And Company Methods of inhibiting Alzheimer's Disease

Also Published As

Publication number Publication date
BE734775A (de) 1969-12-18
DE1931195B2 (de) 1980-01-10
DE1931195C3 (de) 1980-09-11
DE1931195A1 (de) 1970-01-29
ES368147A1 (es) 1971-05-01
FR7461M (de) 1970-01-05
GB1243601A (en) 1971-08-25
US3608066A (en) 1971-09-21

Similar Documents

Publication Publication Date Title
CA931074A (en) Preparation a base d'antigenes bacteriens
CA920168A (en) Connecteur de conduites a garnitures d'etancheite
CA944185A (en) Vilebrequin a maneton d'excentricite variable
CA788684A (en) Jouet a elements modulaires d'encastrement
CA880995A (en) Sechoir a bottes
CA923506A (en) Herbicidal-n-aryl-n'-arylmercaptoureas
CA777814A (en) 2-hexafluoroisopropyl-2'-dichlorotetrafluoroisopropyl diphenate
CA775106A (en) 2-mercaptothiazole-4(5)-carboxy-(2'-nitroanilide)
CA799982A (en) 3-nitro-1-(5-nitrothiazolyl-(2)-2-oxo-tetrahydroimidazoles
AU448931B2 (en) 1 substituted-3 phenoxypyrrolidines
AU422358B2 (en) 59351/69
AU438873B2 (en) Substituted -3-(4) - aroylpiperidines
CA828789A (en) Preparation d'hydroperoxydes
AU5433269A (en) N-bicyclooctyl-n'-dimethylthioureas
AU473821B2 (en) NEW 16 a-ALKYL-STEROIDS
AU291225B2 (en) 12-halo-9(11)-dehydro-spirostanes
CA779309A (en) Triphenyl-tin-(pyridyl-n-oxide-(2))-sulphide
CA750351A (en) Eliminateur d'odeurs
CA767192A (en) Vernis d'emaillage
CA717761A (en) Sequence d'alarme
CA757098A (en) N'-trimethylacetyl-n-phenylalkylsulfamides and -phenylcyclopropylsulfamides
CA798319A (en) Preparation of 17 alpha-ethoxy-6-chloro-6-dehydro-progesterone
CA795797A (en) 1 amino-pyridinium salts
AU445921B2 (en) a BACTERIOPHAGE-PROTEIN CONJUGATE
CA855227A (en) Preparation d'imino-thiazolidines